Q1 2019 13F Holders as of 31 Mar 2019
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
9,222,968
-
Share change
-
+903,965
-
Total reported value
-
$19,459,055
-
Put/Call ratio
-
362%
-
Price per share
-
$2.11
-
Number of holders
-
54
-
Value change
-
+$1,859,587
-
Number of buys
-
22
-
Number of sells
-
22
Institutional Holders of ADAMIS PHARMACEUTICALS CORP - COM NEW (ADMP) as of Q1 2019
As of 31 Mar 2019,
ADAMIS PHARMACEUTICALS CORP - COM NEW (ADMP) was held by
54 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
9,222,968 shares.
The largest 10 holders included
FIRST MANHATTAN CO, VANGUARD GROUP INC, BlackRock Inc., 683 Capital Management, LLC, GEODE CAPITAL MANAGEMENT, LLC, MORGAN STANLEY, SUSQUEHANNA INTERNATIONAL GROUP, LLP, BARCLAYS PLC, BARD ASSOCIATES INC, and Leisure Capital Management.
This page lists
54
institutional shareholders reporting positions in this security
for the Q1 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.